The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bingaman, A. W.
Right arrow Articles by Larsen, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bingaman, A. W.
Right arrow Articles by Larsen, C. P.
The Journal of Immunology, 2000, 164: 3065-3071.
Copyright © 2000 by The American Association of Immunologists

Vigorous Allograft Rejection in the Absence of Danger1

Adam W. Bingaman*, Jongwon Ha*, Seung-Yeun Waitze*, Megan M. Durham*, Hong Rae Cho{dagger}, Carol Tucker-Burden*, Rose Hendrix*, Shannon R. Cowan*, Thomas C. Pearson2,* and Christian P. Larsen2,*

* Carlos and Marguerite Mason Transplantation Research Center, Department of Surgery, Emory University School of Medicine, Atlanta, GA, 30322; and {dagger} Ulsan University Department of Surgery, Ulsan, Korea

Tolerance to self is a necessary attribute of the immune system. It is thought that most autoreactive T cells are deleted in the thymus during the process of negative selection. However, peripheral tolerance mechanisms also exist to prevent development of autoimmune diseases against peripheral self-Ags. It has been proposed that T cells develop tolerance to peripheral self-Ags encountered in the absence of inflammation or "danger" signals. We have used immunodeficient Rag 1-/- mice to study the response of T cells to neo-self peripheral Ags in the form of well-healed skin and vascularized cardiac allografts. In this paper we report that skin and cardiac allografts without evidence of inflammation are vigorously rejected by transferred T cells or when recipients are reconstituted with T cells at a physiologic rate by nude bone graft transplantation. These results provide new insights into the role of inflammation or "danger" in the initiation of T cell-dependent immune responses. These findings also have profound implications in organ transplantation and suggest that in the absence of central deletional tolerance, peripheral tolerance mechanisms are not sufficient to inhibit alloimmune responses even in the absence of inflammation or danger.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Kim, C. K. Chang, T. Hayden, F.-C. Liu, J. Benjamin, J. A. Hamerman, L. L. Lanier, and S.-M. Kang
The Activating Immunoreceptor NKG2D and Its Ligands Are Involved in Allograft Transplant Rejection
J. Immunol., November 15, 2007; 179(10): 6416 - 6420.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. F. LaRosa, A. H. Rahman, and L. A. Turka
The Innate Immune System in Allograft Rejection and Tolerance
J. Immunol., June 15, 2007; 178(12): 7503 - 7509.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. E. Walker, I. W. Nasr, G. Camirand, B. M. Tesar, C. J. Booth, and D. R. Goldstein
Absence of Innate MyD88 Signaling Promotes Inducible Allograft Acceptance
J. Immunol., October 15, 2006; 177(8): 5307 - 5316.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. El-Sawy, J. A. Belperio, R. M. Strieter, D. G. Remick, and R. L. Fairchild
Inhibition of Polymorphonuclear Leukocyte-Mediated Graft Damage Synergizes With Short-Term Costimulatory Blockade to Prevent Cardiac Allograft Rejection
Circulation, July 19, 2005; 112(3): 320 - 331.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Askenasy, E. S. Yolcu, I. Yaniv, and H. Shirwan
Induction of tolerance using Fas ligand: a double-edged immunomodulator
Blood, February 15, 2005; 105(4): 1396 - 1404.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Chalasani, Q. Li, B. T. Konieczny, L. Smith-Diggs, B. Wrobel, Z. Dai, D. L. Perkins, F. K. Baddoura, and F. G. Lakkis
The Allograft Defines the Type of Rejection (Acute versus Chronic) in the Face of an Established Effector Immune Response
J. Immunol., June 15, 2004; 172(12): 7813 - 7820.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Xu, R. Lucas, M. Schuchmann, S. Kuhnle, T. Meergans, A. P. Barreiros, A. W. Lohse, G. Otto, and A. Wendel
GM-CSF Restores Innate, But Not Adaptive, Immune Responses in Glucocorticoid-Immunosuppressed Human Blood In Vitro
J. Immunol., July 15, 2003; 171(2): 938 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Muraille, C. De Trez, B. Pajak, M. Brait, J. Urbain, and O. Leo
T Cell-Dependent Maturation of Dendritic Cells in Response to Bacterial Superantigens
J. Immunol., May 1, 2002; 168(9): 4352 - 4360.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. N. Iwakoshi, T. G. Markees, N. Turgeon, T. Thornley, A. Cuthbert, J. Leif, N. E. Phillips, J. P. Mordes, D. L. Greiner, and A. A. Rossini4
Skin Allograft Maintenance in a New Synchimeric Model System of Tolerance
J. Immunol., December 1, 2001; 167(11): 6623 - 6630.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. C. Anderson, J. M. Carroll, S. Gallucci, J. P. Ridge, A. W. Cheever, and P. Matzinger
Testing Time-, Ignorance-, and Danger-Based Models of Tolerance
J. Immunol., March 15, 2001; 166(6): 3663 - 3671.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. E. Vance
Cutting Edge Commentary: A Copernican Revolution? Doubts About the Danger
J. Immunol., August 15, 2000; 165(4): 1725 - 1728.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.